HI SB2443 | 2020 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 6-0)
Status: Introduced on January 17 2020 - 25% progression, died in committee
Action: 2020-01-23 - Referred to CPH/JDC, WAM.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]
Status: Introduced on January 17 2020 - 25% progression, died in committee
Action: 2020-01-23 - Referred to CPH/JDC, WAM.
Pending: Senate Commerce, Consumer Protection, and Health Committee
Text: Latest bill text (Introduced) [HTML]
Summary
Requires insurers, mutual benefit societies, and health maintenance organizations that provide coverage for prescription insulin drugs to cap the total amount the policyholder, member, or subscriber is required to pay at an amount not to exceed $100 per thirty-day supply of insulin, beginning 1/1/2021. Requires the insurance commissioner with the assistance of the attorney general to investigate prescription insulin drug pricing and submit a report to the legislature, governor, and general public. Appropriates funds.
Title
Relating To Prescription Insulin Drugs.
Sponsors
Sen. Russell Ruderman [D] | Sen. Karl Rhoads [D] | Sen. Rosalyn Baker [D] | Sen. Kaiali'i Kahele [D] |
Sen. Donna Kim [D] | Sen. Maile Shimabukuro [D] |
History
Date | Chamber | Action |
---|---|---|
2020-01-23 | Senate | Referred to CPH/JDC, WAM. |
2020-01-21 | Senate | Passed First Reading. |
2020-01-17 | Senate | Introduced. |
Subjects
Appropriation ($)
DCCA
Health Insurance
Insurance Commissioner
Investigation
Limit
Prescription Insulin Drugs
Pricing
Report
DCCA
Health Insurance
Insurance Commissioner
Investigation
Limit
Prescription Insulin Drugs
Pricing
Report
Hawaii State Sources
Type | Source |
---|---|
Summary | https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=SB&billnumber=2443&year=2020 |
Text | https://www.capitol.hawaii.gov/session2020/bills/SB2443_.HTM |